J7308 – Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ7308
- Long description
- Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- Short description
- Aminolevulinic acid hcl top
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2002
- Last change
- January 1, 2004 – No change
Frequently asked questions
What is HCPCS code J7308?
J7308 is a HCPCS Level II code for aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg).
Does Medicare cover J7308?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J7299 – Intrauterine copper contraceptive (miudella)
- J7300 – Intrauterine copper contraceptive (paragard)
- J7301 – Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7302 – Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
- J7303 – Contraceptive supply, hormone containing vaginal ring, each
- J7304 – Contraceptive supply, hormone containing patch, each
- J7306 – Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307 – Etonogestrel (contraceptive) implant system, including implant and supplies
- J7309 – Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- J7310 – Ganciclovir, 4.5 mg, long-acting implant
- J7311 – Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312 – Injection, dexamethasone, intravitreal implant, 0.1 mg
- J7313 – Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
- J7314 – Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
- J7315 – Mitomycin, ophthalmic, 0.2 mg
- J7316 – Injection, ocriplasmin, 0.125 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.